BREAKFAST SYMPOSIUM
Navigating Advanced Stage HCC: Charting a Course in a Complex Treatment Landscape
SPEAKER: BRANDON M. MEYERS, MSc MD FRCP(C)
A breakfast symposium where we will discuss the multidisciplinary management and selection of frontline systemic treatment options for patients with uHCC in Canada and delve into a number of patient cases where we will apply this knowledge to optimize outcomes for patients with uHCC.
Objectives:
- Appraise the need for the multidisciplinary management of patients with unresectable hepatocellular carcinoma (HCC)
- Evaluate the role of immunotherapy (IO) in the treatment of unresectable HCC and assess how to address safety concerns in patients initiating IO
- Describe how to optimize unresectable HCC treatment based on patient characteristics
LUNCH SYMPOSIUM
Enhancing the Patient Journey: How to Improve Care for HCC Patients?
SPEAKER: BRANDON M. MEYERS, MSc MD FRCP(C)
Moderated by: DR. MAMATHA BHAT
Objectives:
- Review the patient journey from hepatocellular carcinoma (HCC) diagnosis to treatment.
- Discuss holistic approaches to improving care for HCC patients, including improving quality of life.
- Describe how to optimize unresectable HCC treatment based on patient characteristics
BRANDON M. MEYERS, MSc MD FRCP(C)
Dr. Meyers completed medical school at the University of Ottawa. He then completed at McMaster University post-graduate training in Internal Medicine, and Medical Oncology. A fellowship was completed in Gastrointestinal Malignancies.
He is an Associate Professor and staff Medical Oncologist at the Juravinski Cancer Centre, and Associate Member of the Escarpment Cancer Research Institute in Hamilton, Ontario. His gastrointestinal clinical practice primarily focuses on hepatocellular carcinoma.
He recently helped develop the Cancer Care Ontario guidelines on the management of advanced hepatocellular carcinoma, and is Co-Lead on Pathway Management for hepatocellular carcinoma. He is a chair of the Canadian Multidisciplinary HCC Conference.
DR. MAMATHA BHAT
Dr. Mamatha Bhat is a Hepatologist and leads the Transplant AI initiative at the University Health Network's Ajmera Transplant Centre, and Associate Professor of Medicine at the University of Toronto. Dr. Bhat completed her medical school and residency training at McGill University. She then completed a Transplant Hepatology fellowship at the Mayo Clinic in Rochester, Minnesota, followed by a Canadian Institutes of Health Research (CIHR) Fellowship for Health Professionals, through which she completed a PhD.
Dr. Bhat is Partnership & Engagement Lead for the Temerty Centre for AI Research and Education in Medicine (T-CAIREM), Chair of the International Liver Transplant Society Basic and Translational Science Research committee; on the Executive committee of the CDTRP, and an Associate Editor for the American Journal of Transplantation. Dr. Bhat has also been the recipient of recognitions such as the 2022 CIHR-INMD-CASL Early Career Researcher prize, CASL Research Excellence award and the 2021 American Society of Transplantation Basic Science Career Development Award.